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Background and purpose — Criticism of the lateral approach 
(LA) for hip arthroplasty is mainly based on the risk of poor 
patient-reported outcomes compared to the posterior approach 
(PA). However, there have been no controlled studies comparing 
patient-reported outcomes between them. In this randomized 
controlled trial, we tested the hypothesis that patient-reported 
outcomes are better in patients who have undergone total hip 
arthroplasty (THA) with PA than in those who have undergone 
THA with LA, 12 months postoperatively. 
Patients and methods — 80 patients with hip osteoarthritis 
(mean age 61 years) were randomized to THA using PA or the 
modifi ed direct LA. We recorded outcome measures preop-
eratively and 3, 6, and 12 months postoperatively using the Hip 
Disability and Osteoarthritis Outcome Score–Physical Function 
Short Form (HOOS-PS) as the primary outcome. Secondary out-
comes were HOOS-Pain, HOOS-Quality-Of-Life, EQ-5D, UCLA 
Activity Score, and limping. 
Results — We found no statistically signifi cant difference in 
the improvements in HOOS-PS between the treatment groups 
at 12-month follow-up. All secondary outcomes showed similar 
results except for limping, where PA patients improved signifi -
cantly more than LA patients. 
Interpretation — Contrary to our hypothesis, patients treated 
with PA did not improve more than patients treated with LA 
regarding physical function, pain, physical activity, and quality of 
life 12 months postoperatively. However, limping was more pro-
nounced in the LA patients. 
■
The choice of surgical approach in total hip arthroplasty 
(THA) is debated as one factor that may infl uence the patient-
reported outcome (PRO) (Jolles and Bogoch 2004, Hendrickx 
et al. 2014, Repantis et al. 2015) and the risk of revision, 
especially revision due to dislocation (Bystrom et al. 2003, 
Arthursson et al. 2007, Hailer et al. 2012, Lindgren et al. 
2012). Worldwide, the posterior approach (PA) and the lateral 
approach (LA) are 2 of the most commonly used approaches. 
The 2 approaches differ in several ways. The abductor muscles 
are partly detached during the LA procedure but are not dis-
turbed during the PA. The detachment of the abductor muscles 
during LA may infl uence the postoperative outcomes, espe-
cially physical function. Registry-based studies have revealed 
small differences in PROs between the 2 approaches, favoring 
the PA (Amlie et al. 2014, Jameson et al. 2014, Lindgren et 
al. 2014). However, this difference has not been investigated 
in a randomized controlled trial (RCT). A systematic review 
concluded that there is a need for patient-reported evidence 
to support a particular surgical approach (Jolles and Bogoch 
2004). 
We conducted a prospective RCT in patients operated with 
the PA or the LA. The primary aim of this trial was to evalu-
ate the effi cacy of the 2 surgical approaches regarding patient-
reported physical function, and the secondary aims were to 
evaluate their effi cacy regarding patient-reported pain, physi-
cal activity, limping, and quality of life. We hypothesised that 
patient-reported outcomes within the fi rst year would improve 
more in patients who are operated with PA rather than LA. 
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Patients and methods
Design
The trial was a blinded, parallel-group, controlled trial with 
balanced randomization (1:1) following the CONSORT 
guidelines. A full description of the protocol has already been 
published (Rosenlund et al. 2014). 
Participants
Patients were recruited at the Department of Orthopaedic 
Surgery and Traumatology, Odense University Hospital and 
Svendborg Hospital, Funen, Denmark, between May 2012 
and May 2014. The 12-month follow-up was fi nalized in May 
2015. Inclusion and exclusion criteria are given in Table 1. 
All the patients had primary osteoarthritis with indication for 
cementless THA. They were screened for eligibility by hip 
surgeons and by the principal investigator (SR). 
Intervention
All the patients had surgery at Odense University Hospital. 
Preoperative templating was performed using the software 
TraumaCad. Templating was performed to assist in restoring 
an equal leg length and the femoral offset. The surgeons aimed 
at placing the cup within 5–15° of anteversion and 30–50° of 
inclination (Lewinnek et al. 1978).
During surgery, the patients were positioned in the lateral 
decubitus position. All of them received the same types of 
cementless components (Bi-metric stem and Exceed ABT 
Ringloc-x shell and metal head, size 32 mm or 36 mm). 2 
teams of 3 experienced surgeons performed all the operations. 
One team was responsible for the PA procedure and the other 
for the LA procedure.
All patients recived pre- and postoperative antibiotics and 
thromboprophylaxis during the inhospital stay.
Posterior approach 
PA was performed through an incision over the posterior 
part of the greater trochanter through the fascia, followed by 
blunt dissection of gluteus maximus. The external rotators 
were detached and the hip capsule incised (Hoppenfeld et al. 
2009). The hip was dislocated by internal rotation and fl exion. 
During closure of the wound, the capsule was repaired and the 
external rotators were re-inserted  using a heavy absorbable 
suture (coated VICRYL, size 2). 
Lateral approach
LA was performed through a midline incision over the greater 
trochanter and involved detachment of the anterior one-third 
of the gluteus medius insertion and gluteus minimus inser-
tion at the tip of the greater trochanter. The hip capsule was 
excised on the anterior side of the joint, from the basis of the 
collum femoris to the acetabular rim. The hip was dislocated 
by external rotation, adduction and fl exion. During closure of 
the wound, the detached parts of the gluteus medius and mini-
mus were re-inserted using a heavy absorbable suture (coated 
VICRYL, size 2) to re-approximate the divided gluteus mini-
mus and the anterior fl ap of gluteus medius. No capsular repair 
was performed. A detailed description of the approach can be 
found in the work by Mulliken et al. (1998). 
Rehabilitation
The patients were mobilized with 2 canes and allowed full 
weight bearing immediately postoperatively, with no move-
ment restrictions. They received the standard rehabilitation 
care of the department, which has been described in detail 
elsewhere (Rosenlund et al. 2014). 
Data collection
All the patients completed questionnaires preoperatively and 
3, 6, and 12 months postoperatively (with 12 months as the 
primary endpoint). 
Patient-reported outcome measures
Primary outcome 
We used the disease-specifi c Hip Disability and Osteoarthri-
tis Outcome Score–Physical Function Short Form (HOOS-
PS) as the primary outcome. HOOS-PS is a 5-item question-
naire derived from the HOOS subscales of Activities of Daily 
Living (HOOS-ADL) and Sport and Recreation (Davis et al. 
2008). The HOOS-PS score ranges from 0 (extreme symp-
toms) to 100 points (no symptoms). The HOOS-PS has shown 
good validity when compared with the HOOS-ADL, and high 
responsiveness in THA patients (Davis et al. 2009).
Secondary outcomes
We used subscales of the Hip Disability and Osteoarthritis 
Outcome Score (HOOS 2.0)—Pain (HOOS-Pain) and Quality 
Table 1. Inclusion and exclusion criteria
Inclusion criteria
• Aged 45–70 years
• Diagnosed with unilateral primary hip osteoarthritis (OA) or 
 secondary OA due to mild hip dysplasia (center-edge angle > 20°) 
• Scheduled for primary cementless total hip arthroplasty a
Exclusion criteria
• Symptoms in several joints (hip, knee, or ankle) with expected  
total joint arthroplasty within 1 year
• Prior total joint arthroplasty at any joint (hip, knee, or ankle) or 
major lower limb surgery, still causing symptoms
• BMI > 35 
• Any physical disability preventing the patient from walking freely 
without walking aids
• Any neurological disease (e.g. cerebral thrombosis, Parkinson’s 
disease ) compromising walking ability
• Any severe medical condition compromising physical function  
(e.g. chronic heart failure, chronic obstructive pulmonary disease) 
• Severe dementia (OMC < 18)
• Inability to read and understand written and oral instructions in 
Danish
a Cementless Bi-metric stem and Exceed ABT Ringloc-x shell.
OMC: orientation-memory-concentration test. 
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Of Life (HOOS-QOL)—which range from 0 (extreme symp-
toms) to 100 points (no symptoms) (Thorborg et al. 2010, 
Roos 2012).
The patients completed the validated, transcultural, trans-
lated Danish versions of the HOOS-PS, HOOS-Pain, and 
HOOS-QOL (Nilsdotter et al. 2003, Beyer et al. 2008, Thor-
borg et al. 2010). 
EQ-5D-3L
The Danish version of the EuroQol-5-Dimension-3-Likert-
scale Health Questionnaire (EQ-5D-3L) (Brooks 1996, Gudex 
and Sørensen 1998) was used to assess health-related qual-
ity of life. The global health status index ranges from −0.624 
(worst) to 1.0 (best) (Wittrup-Jensen et al. 2009). The overall 
health status (EQ-5D-VAS) is scored on a “thermometer-like” 
100-point visual analog scale from 0 (worst imaginable) to 
100 (best imaginable) (van Reenen and Oppe 2015) . 
UCLA Activity Score
A Danish version of the University of California Los Ange-
les (UCLA) Activity Score was used to measure the patient-
reported activity level. It uses an ordinal 10-point (1–10) Likert 
scale ranging from “wholly inactive: dependent on others” to 
“regularly participate in impact sports or heavy labour”, with 
a higher score being better (Terwee et al. 2011). 
Limping
We used the question about limping from the function domain 
of the Harris hip score (HHS). Limping is scored on an ordinal 
4-point (1–4) Likert scale (no limping; slight, moderate, or 
severe limping), with a lower score being better. This means 
that a single-point change will make the patient change cat-
egory e.g. from no limping to slight limping. The question was 
used to evaluate the patient’s own perception of his/her gait 
function (Mahomed et al. 2001). 
Adverse events 
We performed a medical audit 12 months postoperatively. 
The following complications were registered: deep infection, 
periprosthetic fracture, dislocation, aseptic loosening, nerve 
injury, pulmonary embolism, and deep vein thrombosis.
Data processing
All questionnaires were optimized for digital scanning to 
reduce typing errors (Paulsen et al. 2012). Manual validation 
was performed where ambiguous data occurred. 
Sample size
The sample size calculation was based on the primary outcome 
HOOS-PS, using 1 preoperative assessment and 3 follow-up 
assessments, and an estimated correlation between follow-up 
measurements of 0.5. We considered the minimal clinically 
important difference (MCID) to be 10 points between treat-
ment groups at the 12-month follow-up (Ehrich et al. 2000, 
Roos and Lohmander 2003, Terwee et al. 2009, Roos 2012) 
and used a standard deviation of 16.7 preoperatively and 16.1 
postoperatively (Davis et al. 2009). To achieve a statistical 
power of ß = 0.80 and α = 0.05, 29 patients were needed in 
each treatment group. To account for possible dropouts, 40 
patients were included in each treatment group.
Randomization
Balanced 1:1 block randomization was performed using a 
computer-generated list, with 4 blocks of 20 patients in each. 
The sequence was generated by a third person who was not 
involved in the trial (JL). The sequence was written on paper 
and placed in sealed opaque consecutively numbered enve-
lopes by a secretary not involved in the trial. The envelopes 
were opened in the order given, and the patient was allocated 
to a treatment group and scheduled for surgery.
Blinding
The patients were blinded to treatment and informed, prior 
to participation, that the type of intervention would not be 
revealed to them. The reason for blinding was explained to 
them. Due to the nature of the intervention, the surgeons, 
ward doctors, nurses and physiotherapists were not blinded. 
However, they were all well aware of the importance of not 
discussing the intervention with the patients. Since all the 
patients were treated with the same rehabilitation protocol, 
there was no need to discuss the specifi c intervention. The 
principal investigator was kept blind throughout the trial and 
the statistical analyses. 
Ethics, registration, funding and confl ict of interest 
The trial was approved by the Danish Data Protection Agency 
and the Danish Regional Committee on Biomedical Research 
Ethics (Southern Denmark) (project-ID: S-20120009). 
It was also registered at ClinicalTrials.gov (identifi er: 
NCT01616667).
The trial was supported by the Danish Rheumatoid Asso-
ciation, University of Southern Denmark, Region of Zealand, 
Region of Southern Denmark, the Bevica Foundation, the 
Bjarne Jensen Foundation, and Odense University Hospital. 
None of the trial sponsors played any role in the trial design, 
data collection, data analysis, or interpretation; nor did they 
have any infl uence on the writing of the manuscript or the 
decision to submit the manuscript for publication.
The trial received funding from public and private founda-
tions. One author (SO) has received grants from biomedical 
companies not related to this trial. No other competing inter-
ests declared.
Statistics
Descriptive statistics are reported with mean and standard 
deviation (SD) or median and interquartile range (IQR). 
To evaluate the treatment effect (the mean difference in 
improvement between the PA and LA treatment groups at 12 
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months), we used mixed linear model analysis (with repeated 
measures) and point estimates (Rabe-Hesketh and Skrondal 
2008). This model included the interaction between treatment 
and elapsed time, adjusted for preoperative values and assum-
ing that data were missing completely at random (MCAR) 
(Rabe-Hesketh and Skrondal 2008). Where data were miss-
ing preoperatively, the mean or median preoperative value 
from all the other patients was imputed (used on 3 patients: 2 
UCLA Activity Scores and 1 EQ-5D-VAS). Given the small 
amount of data imputation, it did not change the results. Oth-
erwise, no data imputation was performed. We used the abso-
lute score on the outcome variable as the dependent variable 
with patient as the random effect factor, and based the model 
on the restricted maximum likelihood estimate. The inde-
The statistical analyses were performed using Stata 13.1 
software, with a signifi cance level of 0.05. 
Results
499 patients aged 45–70 years received primary THA in the 
study period (Figure 1). Of these, 151 were not eligible. Of 
the remaining 348 patients, 208 were excluded. 140 patients 
were eligible but 31 declined to participate and, by mistake, 
29 were not asked to participate. 80 patients were randomized 
and 77 and 69 patients were available for the ITT analysis and 
per-protocol analysis, respectively. 
The dropout analysis showed that statistically signifi cantly 
more females and patients with ASA class 2 were present in 
Figure 1. Flow of patients included in the trial. THA: total hip arthroplasty; OA: osteoarthritis; 
ITT: intention-to-treat analysis. a All concepts that were not cementless Bi-metric stem and 
Exceed ABT Ringloc-x shell. b Dropout analysis was performed for these patients.
Patients aged 45–70 years scheduled for THA May 2012 to May 2014 
at Odense University Hospital and Svendborg Hospital, Funen, Denmark
n = 499
Not eligible (n = 151):
– diagnosed with other than primary OA, 126
– scheduled for other prosthetic concepts, 25 a
Excluded (n = 268):
– prior TJA or major surgery of lower limb, 106
– multiple joints with OA and expected TJA within a year, 50
– BMI > 35, 16
– neurological diseases affecting walking ability, 13
– other medical diseases affecting walking ability, 8
– could not walk 20 m without ealking aids, 8
– could not read and/or understand Danish, 2
– other reasons (psychiatric diseases, alcoholism), 10
– declined to participate, 31
– were by mistake not asked to participate, 29 b
Randomized
n = 80
Allocated to posterior approach (n = 41)
Received planned intervention (n = 38)
Excluded (n = 3):
– withdrew consent before surgery, 2
– received other prosthetic concept, 1
Allocated to lateral approach (n = 39)
Received planned intervention (n = 38)
Excluded (n = 1):
– withdrew consent before surgery, 1
3-months follow-up report returned (n = 39)
– not returned, 0
6-months follow-up report returned (n = 39)
– not returned, 0
12-months follow-up report returned (n = 39)
– not returned, 0
3-months follow-up report returned (n = 36)
– not returned, 2
6-months follow-up report returned (n = 37)
– not returned, 1
12-months follow-up report returned (n = 37)
– not returned, 1
Included in the primary ITT analysis (n = 39)
Included in the per protocoll analysis (n = 34)
Excluded (n = 5):
– periprosthetic fracture, 2
– dislocation, 1
– cemented cup, 1
– pelvic fracture, 1
Included in the primary ITT analysis (n = 38)
Included in the per protocoll analysis (n = 35)
Excluded (n = 3):
– Parkinson disease, 1
– aseptic loosening, 1
– did not return any questionnaires, 1
FOLLOW–UP
ELIGIBILITY
ANALYSIS
pendent variables were the preoperative 
values, treatment group, time as a categori-
cal variable, and the interaction between 
treatment group and time. Model assump-
tions were checked with residual plots for 
each dependent variable and were found to 
be acceptable.
The UCLA Activity Score and Limping 
Score were a priori considered as ordinal 
data and treated accordingly. However, 
because of the limited sample size and the 
many categories in each outcome, we mod-
elled the UCLA Activity Score and Limp-
ing Score as numerical scales and used 
mixed linear model analysis as described 
above. 
We performed the primary analyses 
using intention-to-treat (ITT) analysis fol-
lowed by a per-protocol analysis. Effect 
size (using Cohen’s d) was calculated for 
continuous dependent variables. Effect 
sizes of 0.2, 0.5, and 0.8 were defi ned as 
being small, medium, and large, respec-
tively (Cohen 1992). 
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the group of patients who were not included (Appendix A, see 
Supplementary data). 
8 patients (3 in the LA group and 5 in the PA group) did not 
follow the protocol for various reasons (Figure 1).
Preoperative patient characteristics and surgically related 
outcomes are presented in Table 2. There was no difference 
between the groups regarding femoral head size, but more 
patients in the LA group received a lateralized stem. 
Patient-reported outcomes
Within- and between-group change scores are given in Table 
3. We found a statistically non-signifi cant difference in the 
mean change score in HOOS-PS of −3.3 (95% CI: −8.7 to 2.1). 
Thus, the improvement in physical function 12 months post-
operatively following PA treatment was not any better than the 
improvement following LA treatment. The same applies to all 
the earlier time points (Figure 2A). Furthermore, there was no 
additional improvement in the PA group (compared to the LA 
group) in the secondary outcomes at any time-point (HOOS-
Pain, HOOS-QOL, UCLA Activity Score, EQ-5D-3L, and 
Table 2. Demographic and clinical characteristics of patients in 
each treatment group
  
 Lateral Posterior
 approach approach
 (n = 38) (n = 39)
Demographic patient characteristic  
 Male, n  26   26 
 Age at surgery, mean (SD) 60  (7) 62 (6)
 BMI, mean (SD) 27  (3) 28 (4)
 Affected side, right 20  19
 ASA class 1; 2; 3, n 28; 7; 3  30; 6; 3 
 OMC score, mean (SD) 27 (2) 26 (2)
Clinical characteristics
 Preoperative Hgb, mmol/L, mean (SD) 9.1 (0.8) 8.9 (0.6)
 Postoperative Hgb, (mmol/L), mean (SD) 6.9 (1.2) 6.9 (0.9)
 Blood loss, mL, mean (SD) 363 (171) 362 (140)
 Received blood transfusion, n 2 1 
 Anesthesia, n 
    Spinal 32 26
    General   6  13 
 Duration of surgery, min, mean (SD) a 60 (12)  54 (13) 
 Prosthetic head size, n 
    32 mm  30 33
    36 mm   8    6 
 Stem type, n b
    Standard 30 19
    Lateralized    8 20 
Preoperative patient-reported outcomes  
 HOOS-PS, mean (SD) 53 (14) 53 (17)
 HOOS-Pain, mean (SD) 44 (15) 43 (17)
 HOOS-Quality Of Life, mean (SD) 29 (12) 28 (14)
 EQ-5D-3L, mean (SD) 0.6 (0.2) 0.6 (0.2)
 EQ-5D-VAS, mean (SD) 60 (18) 57 (25)
 UCLA Activity Score, median (IQR) 5 (4–7) 5 (3–6)
 Limping Score, median (IQR) 3 (3–3) 3 (3–3)
BMI: body mass index; 
ASA: American Society of Anaesthesiology classifi cation; 
OMC: orientation-memory-concentration test (0 = worst outcome, 28 
= best outcome); 
Hgb: hemoglobin; 
HOOS: Hip Disability and Osteoarthritis Outcome Score (scores 
range from 0 to 100, with higher scores indicating better outcome); 
EQ-5D-3L: European Quality of Life Health Questionnaire (scores 
range from −0.624 to 1.0, with higher scores indicating better 
outcome); 
EQ-5D-VAS: European Quality of Life visual analog scale of overall 
state of health (scores range from 0 to 100 with higher scores 
indicating better outcome); 
UCLA Activity Score: the University of California Los Angeles Activity 
Score (scores range from 1 to 10 with higher scores indicating 
better outcome). 
Limping score: ranges from 1 (no limping) to 4 (severe limping). 
a Signifi cant difference between treatment groups tested with Stu-
dent’s t-test.
b Signifi cant difference with the chi-square test. 
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Figure 2. HOOS-PS (top panel), HOOS-Pain (middle panel) and 
HOOS-QoL (quality of life; bottom panel), by time and treatment group. 
Mean scores with 95% CI.
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EQ-5D-VAS) (Figures 2 and 4, and Table 3). A signifi cant 
between-group difference in favor of PA was observed for 
became relatively well-functioning despite sequelae with a 
drop foot.   
1.0
0.5
0.4
0.3
0.2
0.1
0
0.6
0.7
0.8
0.9
Preop 3 months 6 months 12 months
Mean EQ5D-3L index (95% CI)
Posterior approach
Lateral approach
100
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Preop 3 months 6 months 12 months
EQ5D–VAS (95% CI)
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Preop 3 months 6 months 12 months
UCLA activity score (95% CI)
4.0
1.5
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2.0
2.5
3.0
3.5
Preop 3 months 6 months 12 months
Limping score (95% CI)
Figure 3. EQ-5D-3L (left panel)  and EQ-5D-VAS (right panel) by time and treatment 
group. Mean scores with 95% CI.
Figure 4. UCLA Activity Score and Limping Score, by time and treatment group. 
Mean scores with 95% CI.
Table 3. Mean difference in patient-reported outcomes within and between treatment groups preoperatively to 12-month 
follow-up (intention to treat). Values are mean (95% CI) unless otherwise indicated 
  Between-group change   
 Within-group change   (LA minus PA) a Cohen’s d,
 Preoperatively to 12-month follow-up Preoperatively to  effect size (ES)
 Lateral approach      Posterior approach  12-month follow-up 12-month follow-up
PROM (n = 37) (n = 39) (n = 77) p-value ES (95% CI)
HOOS-PS 36 (30 to 42) 39 (35 to 44) −3.3 (−9 to 2) 0.2 0.3 (−0.2 to 0.7)
HOOS-Pain 46 (40 to 53) 50 (44 to 55) −2.6 (−9 to 4) 0.4 0.1 (−0.3 to 0.6)
HOOS-QOL 51 (42 to 59) 56 (50 to 61) −4.9 (−13 to 4) 0.3 0.2 (−0.2 to 0.7)
EQ-5D-3L 0.3 (0.2 to 0.3) 0.3 (0.3 to 0.4) −0.04 (−0.11 to 0.03) 0.3 0.1 (−0.4 to 0.5)
EQ-5D-VAS 24 (16 to 32) 30 (23 to 38) −5 (−12 to 3) 0.2 0.2 (−0.2 to 0.7)
UCLA Activity   1 (0 to 3) c   2 (1 to 3) c −0.6 (−1.3 to 0.0) 0.06 – b
Limping Score −1 (−2 to −1) c −2 (−2 to −1) c  0.4 (0.0 to 0.7) 0.02 – b
For PROM abbreviations, see Table 2
a Results from a random-effects mixed linear model analysis (repeated measures) with PROM variable as the dependent 
variable and preoperative value, treatment, time, and interaction between time and treatment as independent variables. 
Data from all assessment time points (preoperatively and 3, 6, and 12 months postoperatively) were used in the model.  
A numerically positive value indicates a better outcome for LA, except for limping.
b Cohen’s effect size was not calculated due to the ordinal nature of the outcome. 
c median  (IQR)
limping (0.4, 95% CI: 0.0–0.7) (Figure 4 and Table 
3). Collectively, all outcome measures tended to 
have a higher numeric improvement for PA. The 
effect size (Cohen’s d) for the primary outcome at 
12 months was small (0.3, 95% CI: −0.2 to 0.7) 
(Table 3). 
The per-protocol analysis changed the results on 
limping to a statistically non-signifi cant improve-
ment in favor of PA. All other results remained 
unchanged (Appendix B, see Supplementary 
data). A signifi cant within-group improvement in 
HOOS-PS was observed in both treatment groups: 
39 (95% CI: 35–44) and 36 (95% CI: 30–42) for 
PA and LA, respectively. The greatest improve-
ment in all outcomes occurred within the fi rst 3 
months (Figures 2-4). 
A number-needed-to-treat analysis is available 
in Appendix C (see Supplementary data).
Adverse effects
5 patients in the PA group had adverse events. 2 
had a periprosthetic fracture within 1 month of sur-
gery (1 accidentally fell; the other had a peropera-
tive fi ssure in the proximal femur, probably leading 
to the periprosthetic fracture). Both patients had a 
revision and became well-functioning. 1 had a dis-
location 3 weeks postoperatively, was treated with 
closed reduction, and became well-functioning. 
2 patients had a deep vein thrombosis and were 
treated medically. 1 patient in the LA group had 
a revision due to aseptic loosening of the stem. He 
9907 Rosenlund D.indd   6 2/16/2017   12:23:34 PM
Acta Orthopaedica 2017; 88 (x): x–x 7
Discussion
The main aim of this trial was to investigate whether the effi -
cacy—evaluated by improvement in patient-reported out-
come—was better in patients who underwent THA with PA 
rather than THA with  LA, 12 months postoperatively.
Contrary to our hypotheses, no statistically signifi cant dif-
ference in improvement in physical function was observed 
between the patients in the 2 groups. The same applied to the 
secondary outcomes except for limping, where patients in the 
PA group improved more than the patients in the LA group. 
There was, however, a systematic tendency towards higher 
numeric improvements in the PA group, ranging from 2.6 to 
4.9 points on HOOS-Pain, HOOS-PS and HOOS-QOL, than 
in the LA group. These fi ndings are in agreement with a cohort 
study of 852 THA patients operated with LA or PA, with 1–3 
years  of follow-up. That study showed a statistically signifi -
cant difference of 4.0 points on the HOOS-ADL subscale in 
favor of the PA group (Amlie et al. 2014). Also, a randomized 
study with 3-month follow-up showed this tendency in both 
surgeon-reported and patient-reported outcomes (Witzleb et 
al. 2009), although the differences were not statistically sig-
nifi cant. 
We found a between-group difference in general health 
status (EQ-5D-3L) of −0.04 (95% CI: −0.1 to 0.03). This cor-
responds to fi ndings from a registry-based study of 42,233 
THA patients with 6 years of follow-up. That study showed 
a statistically signifi cantly better EQ-5D outcome (by 0.03) in 
favor of the PA group (Lindgren et al. 2014). However, the dif-
ferences in both HOOS and EQ-5D between the 2 approaches 
were small, and it can be questioned whether the differences 
are above the minimal clinically important difference (MCID) 
(Ehrich et al. 2000, Roos and Lohmander 2003, Terwee et al. 
2009, Larsen et al. 2010, Roos 2012, Coretti et al. 2014). The 
effect size (Cohens’ d) also supports this notion, as the effect 
size for all outcomes was small to negligible.
We based the sample size calculation on the HOOS-PS 
subscale with 10 points as the MCID between groups. This 
decision was based on published evidence and related RCT 
studies using the HOOS questionnaire as the primary outcome 
measure (Ehrich et al. 2000, Roos and Lohmander 2003, 
Terwee et al. 2009, Roos 2012, Skou et al. 2012, Villadsen et 
al. 2014). We cannot rule out the possibility of type-II error 
in our study, if the MCID is less than 10 points as we used. 
A post-hoc sample size calculation showed that to detect a 
statistically signifi cant between-group difference in HOOS- 
Physical Function of 3.3 points, using the standard devia-
tions from our trial, 183 patients would be required in each 
treatment group. However, we consider that the statistically 
non-signifi cant between-group difference of ~3 HOOS points 
in all the HOOS subscales included, in favor of PA, was not 
clinically relevant—based upon current evidence (Frobell et 
al. 2008, Roos 2012, Villadsen et al. 2014, Kise et al. 2015, 
Kise et al. 2016). This does not imply that there could be no 
other clinically signifi cant differences than those investigated 
in our study. 
We found that patients in the PA group reported having 
less limping than patients in the LA group, which may be 
explained by the disturbance of the abductor muscles (Maso-
nis and Bourne 2002, Edmunds and Boscainos 2011, Amlie 
et al. 2014). The difference was, however, less than 1 point. 
A single-point change is what differentiates 2 categories, e.g. 
the difference between no limping and slight limping on the 
4-point Likert scale. The difference was not statistically signif-
icant in the per-protocol analysis. Our results are in line with 
those from a cohort study that found twice as many patients 
in the LA group with self-reported limping at 1–3 years post-
operatively (Amlie et al. 2014). That study also found that the 
difference in mean score between patients with and without 
self-reported limping ranged from 17 to 35 on the 5 HOOS 
subscales, in favor of the non-limping patients. In contrast 
to our results, a Cochrane review based on 4 non-random-
ized cohort studies found no differences in limping between 
patients operated with LA or with PA, as measured with the 
Trendelenburg test (Jolles and Bogoch 2004). Also, the study 
by Winther et al. (2015) could not detect any difference in hip 
muscle strength at 3 months between the PA patients and the 
LA patients. However, the patients’ perception—and hence 
response to the question—of limping may not match an objec-
tive measurement of limping. 
Strengths and limitations
Regarding strengths, the study was a thoroughly executed, 
randomized controlled trial following the CONSORT state-
ment. We randomized the patients to a specifi c approach that 
automatically included a specifi c team of surgeons with skills 
in that particular approach, thus avoiding bias due to a learn-
ing curve. To avoid the risk of comparing surgeon skills or sur-
geon preference rather than the surgical procedure, 3 equally 
experienced surgeons participated in each team. 
Regarding limitations, the study was designed as a supe-
riority trial. We cannot therefore conclude that LA is not 
inferior to PA. If the clinically relevant difference was less 
than 10 points on the HOOS subscales, the study may have 
been underpowered to show this with a statistically signifi -
cant value. Furthermore, this trial was designed to investigate 
group differences between PA and LA rather than at the indi-
vidual level, which has been suggested by Katz et al. (2015). 
At the individual level, we found that 23 patients in the LA 
group had a HOOS-PS score of over 88 points—as compared 
to 27 in the PA group, giving a non-signifi cant absolute risk 
reduction of 7% (95% CI: −14 to 28). The number needed to 
treat (NNT) was 14 in favor of PA, but the result was not sta-
tistically signifi cant based on the present sample size (Appen-
dix C, see Supplementary data). 
Blinding of both the patients and the principal investigator 
performing the analyses was maintained almost completely 
throughout the trial, due to the nature of the self-reported 
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outcomes and through the discretion of the hospital person-
nel. We are aware that a few patients may have guessed their 
intervention. However, we did not systematically measure the 
success of blinding.
Disadvantages related to THA surgery, such as disloca-
tion rates and revision rates, are relevant to include in the 
investigation of potential differences between the 2 surgical 
approaches, but this would require a longer follow-up and a 
study design with a larger sample size (Jolles and Bogoch 
2004). These issues should be addressed before making any 
fi rm conclusion about the superiority of one approach over 
the other.  
Generalizability
Not all eligible patients (43%) were included in the trial, which 
may have reduced the external validity. The strict exclusion 
criteria may have limited any generalizability of the results 
to other patient groups. However, 80% of all THA patients 
are diagnosed with primary osteoarthritis (Overgaard 2013), 
so the patients in this trial represent the vast majority of all 
THA patients. 
Conclusion
We found no superior effi cacy of using the PA compared with 
LA, as evaluated from patient-reported physical function, 
pain, physical activity, and quality of life. However, patients 
operated using the PA had less self-reported limping at 12 
months. A future multicenter non-inferiority RCT would be 
valuable to investigate whether there are signifi cant differ-
ences in revision rates between THAs performed with the LA 
and with the PA. 
Supplementary data
Appendices A–C are available as supplementary data in the 
online version of the article http://dx.doi.org/10.1080/174536
74.2017.1291100.
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